Rohatiner AZ - Search Results

1

Oral idarubicin as a palliative agent in leukemia.

Davis CL, Rohatiner AZ, Amess JA, Lister TA. Davis CL, et al. Among authors: rohatiner az. Hematol Oncol. 1991 Jan-Feb;9(1):59-60. doi: 10.1002/hon.2900090108. Hematol Oncol. 1991. PMID: 1710595 Clinical Trial. No abstract available.

2

Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy.

Whelan JS, Davis CL, Rohatiner AZ, Leahy M, MacCallum PK, Gupta RK, Matthews J, Norton AJ, Amess JA, Lister TA. Whelan JS, et al. Among authors: rohatiner az. Hematol Oncol. 1992 Mar-Apr;10(2):87-94. doi: 10.1002/hon.2900100204. Hematol Oncol. 1992. PMID: 1592366

3

Acute myeloid leukemia in elderly adults.

Tucker J, Thomas AE, Gregory WM, Ganesan TS, Malik ST, Amess JA, Lim J, Willis L, Rohatiner AZ, Lister TA. Tucker J, et al. Among authors: rohatiner az. Hematol Oncol. 1990 Jan-Feb;8(1):13-21. doi: 10.1002/hon.2900080103. Hematol Oncol. 1990. PMID: 1688820

4

Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in Hodgkin's disease.

Oza AM, Leahy M, Dorey E, Davis CL, Amess J, Horton M, Rohatiner AZ, Wrigley PF, Lister TA. Oza AM, et al. Among authors: rohatiner az. Hematol Oncol. 1991 Nov-Dec;9(6):337-47. doi: 10.1002/hon.2900090608. Hematol Oncol. 1991. PMID: 1748400

5

Oral idarubicin in the treatment of acute myelogenous leukaemia and the blast phase of chronic myeloid leukaemia.

Malik ST, Tucker J, Rohatiner AZ, Brace W, Lister TA. Malik ST, et al. Among authors: rohatiner az. Hematol Oncol. 1989 Nov-Dec;7(6):423-7. doi: 10.1002/hon.2900070605. Hematol Oncol. 1989. PMID: 2807180

6

The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival.

Karmiris T, Rohatiner AZ, Love S, Carter M, Ganjoo RK, Amess J, Norton AJ, Lister TA. Karmiris T, et al. Among authors: rohatiner az. Hematol Oncol. 1994 Jan-Feb;12(1):29-39. doi: 10.1002/hon.2900120105. Hematol Oncol. 1994. PMID: 7515019

7

Recombinant interferon-alpha 2b and high dose methyl prednisolone in relapsed and resistant multiple myeloma.

Ganjoo RK, Johnson PW, Evans ML, Williams A, Rohatiner AZ, Lister TA, Malpas JS. Ganjoo RK, et al. Among authors: rohatiner az. Hematol Oncol. 1993 Jul-Aug;11(4):179-86. doi: 10.1002/hon.2900110403. Hematol Oncol. 1993. PMID: 8144132

8

Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine.

Dalley CD, Lillington DL, Bradburn M, Carter M, Amess JA, Rohatiner AZ, Lister TA. Dalley CD, et al. Among authors: rohatiner az. Hematol J. 2002;3(5):237-43. doi: 10.1038/sj.thj.6200188. Hematol J. 2002. PMID: 12391541

9

Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia.

Lillington DM, Micallef IN, Carpenter E, Neat MJ, Amess JA, Matthews J, Foot NJ, Lister TA, Young BD, Rohatiner AZ. Lillington DM, et al. Among authors: rohatiner az. Ann Oncol. 2002;13 Suppl 1:40-3. doi: 10.1093/annonc/13.s1.40. Ann Oncol. 2002. PMID: 12078901 Free article.

10

Waldenstrom's macroglobulinemia: a retrospective analysis of 40 patients from 1972 to 2001.

Ngan S, Rohatiner AZ, Matthews J, Williams A, Amess JA, Norton A, Lister TA. Ngan S, et al. Among authors: rohatiner az. Semin Oncol. 2003 Apr;30(2):236-8. doi: 10.1053/sonc.2003.50083. Semin Oncol. 2003. PMID: 12720143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters